Patient and mouse antibodies against dengue virus nonstructural protein 1 cross-react with platelets and cause their dysfunction or depletion

American Journal of Infectious Diseases

Volumn 4, Issue 1, 2008, Pages 69-75

  Lin, Chiou Feng ^a   Lei, Huan Yao ^a   Liu, Ching Chuan ^a   Liu, Hsiao Sheng ^a   Yeh, Trai Ming ^a   Anderson, Robert ^b   Lin, Yee Shin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Autoantibody; Dengue virus; NS1; Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIBODY; NONSTRUCTURAL PROTEIN 1; RECOMBINANT NONSTRUCTURAL PROTEIN 1; RECOMBINANT PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOT LYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE DYSFUNCTION; THROMBOCYTOSIS;

EID: 58449134568     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2008.69.75     Document Type: Article

References (34)

1. Henchal, E.A. and J.R. Putnak, 1990. The dengue viruses. Clin. Microbiol. Rev., 3: 376-396.
2. Gubler, D.J., 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev., 11: 480-496.
3. Halstead, S.B., 1988. Pathogenesis of dengue: challenges to molecular biology. Science, 239: 476-481.
4. Halstead, S.B., 2002. Dengue. Curr. Opin. Infect. Dis., 15: 471-476.
5. Morens, D.M., 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis., 19: 500-512.
6. Halstead, S.B., 12003. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res., 60: 421-467.
7. Mady, B.J., D.V. Erbe, I. Kurane, M.W. Fanger and F. A. Ennis, 1991. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcy receptors. J. Immunol., 147: 3139-3144.
8. Huang, K.J., Y.C. Yang, Y.S. Lin, J.H. Huang, H.S. Liu, T.M. Yeh, S.H. Chen, C.C. Liu and H.Y. Lei, 2006. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol., 176: 2825-2832.
9. Rothman, A.L. and F.A. Ennis, 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology, 257: 1-6.
10. Lei, H.Y., T.M. Yeh, H.S. Liu, Y.S. Lin, S.H. Chen and C.C Liu, 2001. Immunopathogenesis of dengue virus infection. J. Biomed. Sci., 8: 377-388.
11. Green, S. and A. Rothman, 2006. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis., 19: 429-436.
12. Clyde K, J.L. Kyle and E. Harris, 2006, Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol., 80: 11418-11431.
13. Rothman, A.L., 2004. Dengue: defining protective versus pathologic immunity. J. Clin. Invest., 113: 946-951.
14. King, C.A., J.S. Marshall, H. Alshurafa and R. Anderson, 2000. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J. Virol., 74: 7146-7150.
15. Malasit, P., 1987. Complement and dengue haemorrhagic fever/shock syndrome. Am. J. Trop. Med. Hyg., 18: 316-320.
16. Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi and M. Husmann, 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation and apoptosis. J. Immunol., 161: 6338-6346.
17. Green. S., D.W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B.L. Innis, I. Kurane, A.L. Rothman and F.A. Ennis, 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis., 179: 755-762.
18. Mongkolsapaya, J., W. Dejnirattisai, X.N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, P. Yenchitsomanus, A. McMichael, P. Malasit and G. Screaton, 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med., 9: 921-927.
19. Falconar, A.K.I., 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol., 142: 897-916.
20. Chaturvedi, U.C., E.A. Elbishbishi, R. Agarwal and A.S. Mustafa, 2001. Cytotoxic factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol. Med. Microbiol., 30: 181-186.
21. Lin, C.F., S.W. Wan, H.J. Cheng, H.Y. Lei and Y.S. Lin, 2006. Autoimmune pathogenesis in dengue virus infection. Viral Immunol., 19: 127-132.
22. Rigau-Perez, J.G., G.G. Clark, D.J. Gubler, P. Reiter, E.J. Sanders and A.V. Vorndam, 1998. Dengue and dengue haemorrhagic fever. Lancet, 352: 971-977.
23. Hathirat, P., P. Isarangkura, T. Srichaikul, V. Suvatte and C. Mitrakul, 1993. Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health, 24: 80-85.
24. Nakao, S., C.J. Lai and N.S. Young, 1989. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood, 74: 1235-1240.
25. Murgue, B., O. Cassar, M. Guigon and E. Chungue, 1997. Dengue virus inhibits human hematopoietic progenitor growth in vitro. J. Infect. Dis., 175: 1497-1501.
26. Wang, S., R. He, J. Patarapotikul, B.L. Innis and R. Anderson, 1995. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology, 213: 254-257.
27. Butthep, P., A. Bunyaratvej and N. Bhamarapravati, 1993. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Am. J. Trop. Med. Hyg., 24: 246-249.
28. Lin, C.F., H.Y. Lei, C.C. Liu, H.S. Liu, T.M. Yeh, S.T. Wang, T.I. Yang, F.C. Sheu, C.F. Kuo and Y.S. Lin, 2001. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol., 63: 143-149.
29. Huang, K.J., S.Y. Li, S.C. Chen, H.S. Liu, Y.S. Lin, T.M. Yeh, C.C. Liu and H.Y. Lei, 2000. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol., 81: 2177-2182.
30. Lin, C.F., H.Y. Lei, A.L. Shiau, C.C. Liu, H.S. Liu, T.M. Yeh, S.H. Chen and Y.S. Lin, 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol., 69: 82-90.
31. van Gorp, E.C.M., C. Suharti, H. ten Cate, W.M.V. Dolmans, J.W.M. van der Meer, J.W. ten Cate and D.P.M. Brandjes, 1999. Review: infectious diseases and coagulation disorders. J. Infect. Dis., 180: 176-186.
32. Srichaikul, T., S. Nimmannitya, T. Sripaisarn, M. Kamolsilpa and C. Pulgate, 1989. Platelet function during the acute phase of dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health, 20: 19-25.
33. Kaplan, C., F. Morinet and J. Cartron, 1992. Virus-induced autoimmune thrombocytopenia and neutropenia. Semin. Hematol., 29: 34-44.
34. Boughton, B.J., A.W. Simpson, C. Bolt, A. Buchan and P. McLeish, 1995. Platelet membrane glycoprotein IIb/IIIa has sequence homologies with human virus proteins and synthetic viral peptides inhibit anti-GPIIb/ IIIa antibodies in autoimmune thrombocytopenic purpura. Platelets, 6: 75-82.